Patterns and predictors of therapeutic response to efgartigimod in acetylcholine receptor-antibody generalized myasthenia gravis subtypes

• Published in: Therapeutic advances in neurological disorders Vol. 18; p. 17562864251319656
• Main Authors: Jin, Lei, Zou, Zhangyu, Wang, Qinzhou, Zeng, Wenshuang, Jiang, Qilong, Chen, Jing, Shi, Jianquan, Yu, Yanyan, Hong, Daojun, Zeng, Quantao, Tan, Song, Yue, Yaoxian, Zhang, Zhouao, Zhang, Yong, Guo, Xiuming, Du, Lei, Zhao, Zhongyan, Huang, Shixiong, Chen, Ying, Wu, Zongtai, Yan, Chong, Xi, Jianying, Song, Jie, Luo, Sushan, Zhao, Chongbo
• Format: Journal Article
• Language: English
• Published: England SAGE Publications 01.01.2025; SAGE Publishing
• Subjects: Original Research; early-onset; thymoma; late-onset; efgartigimod; therapeutic response; generalized myasthenia gravis

Plain language summary Patterns and predictors of therapeutic response to efgartigimod in AChR generalized myasthenia gravis Myasthenia Gravis (MG) is an autoimmune disorder that can lead to potentially life-threatening complications. Efgartigimod is an approved biologic for generalized myasthenia g...